Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Hikal

Sector: Healthcare | Industry: Drugs & Pharma
R 140.15 0.75  | 0.54% -4.69% 15.39 1,729.91
NSE Price: Oct 22, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 15:57 140.15 0.75 0.54% 140.90 139.40 176,967 139.45 - 142.80
BSE Oct 22, 2019 140.30 1.00 0.72% 140.00 139.30 24,955 139.75 - 142.55
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 163,032 P/B: 2.21 NSE Code: HIKAL
52-Week Range: R 136.10 - 187.70 Dividend Yield: 0.86% BSE Code: 524735
TTM EPS: R 9.11 Book Value: R 63.38 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Hikal -10.29 -10.01 -6.84 -4.43 -2.07 8.89 11.20
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 22.65 19.75 13.90
Net Profit 33.47 35.75 10.04
EPS 33.47 35.75 10.04
Book Value 12.97 18.17 13.72
Average
Operating Margin 18.90 19.27 19.73
Net Margin 6.48 6.36 5.63
Return on Networth 14.46 13.11 11.69
Return on Investment 15.25 13.31 12.87
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -11.88 23.82 -11.88
Operating Profit -17.66 20.39 -17.66
Net Profit -24.33 58.38 -24.33
EPS -24.33 58.37 -24.33
TTM
Revenue 4.88 22.68 4.88
Operating Profit 3.96 21.84 3.96
Net Profit 9.02 40.76 9.02
EPS 9.02 40.75 9.02
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Hikal 1,729.91 1,667.17 112.38 6.73 14.46 2.21 15.39
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 24, 2018 International Finance Corporation FDI AC  Sell Market 100,207 139.95 140.24
Jan 04, 2018 Reliance Capital Trustee Co Ltd  Sell Market 185,366 244.85 453.87
Oct 13, 2017 International Finance Corporation FDI AC  Sell Market 173,466 247.60 429.50
May 21, 2014 Gayatri Trust  Sell Market 5,000 455.30 22.77
May 21, 2014 Ishaan Trust  Sell Market 5,000 455.30 22.77
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Canara Robeco Mutual Fund 1.488 1.488 1.368 0.987 1.212
Sundaram Mutual Fund 0.539 0.456 0.396 0.150 -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Hikal Ltd.

Address: 717 / 718, Maker Chambers V, Nariman Point, Mumbai, Maharashtra - 400021 | Phone: 66301801 / 22834587 | Fax: 22833913

Email: [email protected]

Website: www.hikal.com

Registrar & Transfer Agent: Universal Capital Securities Pvt. Ltd

Address: (Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas , Opp. Satya Saibaba Temple,Mahakali Caves Road,Andheri (E),Mumbai, (Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas, Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E) | Phone: 022-28366620/28257641 | Fax: 022-28366620

Email: [email protected]

Essential checks
Altman Z-Score
3.09
Piotroski F-Score
7
Modified C-Score
0
5-Years Price to Earnings
15.39
5-Years Price to Book
2.21
Earnings Yield
EBIT / Enterprise value
9.20%
PEG
Price / Earnings to growth ratio
0.56
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59